( SEVAMED 2002)

(Diagnosis, Diagnostics, Immunodiagnosis, Immunodiagnostics, Pathogenesis,  Vaccines & Drugs)

Click Here for Abstract

Back To Content Page

3259.      Akuta N.  Chayama K. Suzuki F.  Someya T. Kobayashi M.  Tsubota A.  Suzuki Y. Saitoh S. Arase Y.  Ikeda K.  Kumada H. Risk factors of hepatitis C virus-related liver cirrhosis in young adults: positive family history of liver disease and transporter associated with antigen processing 2(TAP2)*0201 Allele. Journal of Medical Virology. 64(2):109-16, 2001 Jun.

3260.      Al-Sheyyab M.  Batieha A. El-Khateeb M.  The prevalence of hepatitis B, hepatitis C and human immune deficiency virus markers in multi-transfused patients.  Journal of Tropical Pediatrics.  47(4):239-42, 2001 Aug.

3261.      Andries S.  Casamayou L.  Sempoux C.  Burlet M.  Reding R. Bernard Otte J.  Buts JP. Sokal E. Posttransplant immune hepatitis in pediatric liver transplant recipients: incidence and maintenance therapy with azathioprine.  Transplantation.  72(2):267-72, 2001 Jul 27.

3262.      Andriulli A.  Festa V. Leandro G.  Rizzetto M. Usefulness of a liver biopsy in the evaluation of patients with elevated ALT values and serological markers of hepatitis viral infection: an AIGO study. Digestive Diseases & Sciences. 46(7):1409-15, 2001 Jul.

3263.      Aoyagi K.  Iida K. Ohue C.  Matsunaga Y.  Tanaka E. Kiyosawa K.  Yagi S. Performance of a conventional enzyme immunoassay for hepatitis C virus core antigen in the early phases of hepatitis C infection. Clinica y Laboratorio.  47(3-4):119-27, 2001.

3264.      Arens M.  Clinically relevant sequence-based genotyping of HBV, HCV, CMV, and HIV. [Review] [62 refs] Journal of Clinical Virology.  22(1):11-29, 2001 Aug.

3265.      Badur S.  Akgun A. Diagnosis of hepatitis B infections and monitoring of treatment. [Review] [33 refs] Journal of Clinical Virology.  21(3):229-37, 2001 Jun.

3266.      Barrett S.  Goh J. Coughlan B.  Ryan E.  Stewart S. Cockram A.  O'Keane JC.  Crowe J. The natural course of hepatitis C virus infection after 22 years in a unique homogenous cohort: spontaneous viral clearance and chronic HCV infection. Gut. 49(3):423-30, 2001 Sep.

3267.      Bhatia V, Swami H M. Assessment of hepatitis B vaccine coverage by using the national immunization day in Chandigarh. Indian J med Sci. 54(8): 347-9, 2000.

3268.      Cantaloube JF.  Gallian P. Attoui H.  Biagini P. De Micco P. De Lamballerie X. Erroneous HCV genotype assignment by a hybridization typing assay in a case of posttransfusion HCV infection.  Transfusion.  41(3):429-30, 2001 Mar.

3269.      Cashman TM.  Elm JL Jr. Wu M.  Tom T.  Effler PV. Hepatitis C, diagnosis and management: a survey of practicing physicians in Hawaii.  Hawaii Medical Journal.  60(6):148-54, 2001 Jun.

3270.      Chandrasekaran S, Palaniappan N, Krishnan V, Mohan G, Chandrasekaran N. Relative prevalence of hepatitis B viral markers and hepatitis C virus antibodies(anti HCV) in Madurai, south India. Indian J med Sci. 54(7): 270-3, 2000.

3271.      Chitambar S D, Chadha M S. Use of filter paper disc for hepatitis A surveillance. Indian J Gastroenterol.19(4):165-7, 2000.

3272.      Cho JW.  Baek WK. Suh SI.  Yang SH.  Chang J. Sung YC.  Suh MH.  Hepatitis C virus core protein promotes cell proliferation through the upregulation of cyclin E expression levels.  Liver. 21(2):137-42, 2001 Apr.

3273.      Chu CW.  Hwang SJ. Luo JC.  Lai CR.  Tsay SH. Li CP.  Wu JC.  Chang FY. Lee SD. Clinical, virologic, and pathologic significance of elevated serum alpha-fetoprotein levels in patients with chronic hepatitis C.  Journal of Clinical Gastroenterology.  32(3):240-4, 2001 Mar.

3274.      Du B.  You S. Present situation in preventing and treating liver fibrosis with TCM drugs. [Review] [26 refs]  Journal of Traditional Chinese Medicine. 21(2):147-52, 2001 Jun.

3275.      Erensoy S.  Diagnosis of hepatitis C virus (HCV) infection and laboratory monitoring of its therapy. [Review] [45 refs]  Journal of Clinical Virology.  21(3):271-81, 2001 Jun.

3276.      Fabrizi F.  Martin P. Dixit V.  Quan S.  Brezina M. Kaufman E.  Sra K.  Mousa M. DiNello R.  Polito A. Gitnick G. Automated RIBA HCV strip immunoblot assay: a novel tool for the diagnosis of hepatitis C virus infection in hemodialysis patients. American Journal of Nephrology.  21(2):104-11, 2001 Mar-Apr.

3277.      Funato T.  Satou N. Abukawa D.  Satou J. Abe Y. Ishii KK.  Iinuma K.  Kaku M. Sasaski T.  Quantitative evaluation of cytomegalovirus DNA in infantile hepatitis. Journal of Viral Hepatitis. 8(3):217-22, 2001 May.

3278.      Gopalani A.  Ahuja TS. Prevalence of glomerulopathies in autopsies of patients infected with the hepatitis C virus.  American Journal of the Medical Sciences.  322(2):57-60, 2001 Aug.

3279.      Hahn JA.  Page-Shafer K.  Lum PJ.  Ochoa K.  Moss AR. Hepatitis C virus infection and needle exchange use among young injection drug users in San Francisco. Hepatology.  34(1):180-7, 2001 Jul.

3280.      Halfon P.  Trimoulet P.  Bourliere M.  Khiri H.  de Ledinghen V.  Couzigou P. Feryn JM.  Alcaraz P. Renou C. Fleury HJ.  Ouzan D. Hepatitis C virus genotyping based on 5' noncoding sequence analysis (Trugene). Journal of Clinical Microbiology. 39(5):1771-3, 2001 May.

3281.      Hitzler WE.  Runkel S. Routine HCV PCR screening of blood donations to identify early HCV infection in blood donors lacking antibodies to HCV. Transfusion.  41(3):333-7, 2001 Mar.

3282.      Kapoor S, Gupta R K, Das B C, Kar P. Clinical implications of hepatitis G virus (HGV) infection in patients of acute viral hepatitis and fulminant hepatic failure. Indian J med Res. 112(Oct): 121-32, 2001.

3283.      Kocak N, Ozen H, Saltik I N, Yuce A, Gurakan F. Recombinant interferon-alfa therapy in children with chronic hepatitis B and cured cancer. Indian J Gastroenterol.19(4): 197-8, 2000.

3284.      Koff RS. Risks associated with hepatitis A and hepatitis B in patients with hepatitis C. [Review] [36 refs]  Journal of Clinical Gastroenterology.  33(1):20-6, 2001 Jul.

3285.      Kozlowski A.  Charles SA. Harris JM.  Development of pegylated interferons for the treatment of chronic hepatitis C. [Review] [46 refs]  Biodrugs.  15(7):419-29, 2001.

3286.      Levis J.  Kenny-Walsh E.  O'Sullivan K.  Horgan M.  Whelton M.  Shanahan F.  Fanning L. Strategy for the maximization of clinically relevant information from hepatitis C virus, RT-PCR quantification. Journal of Clinical Virology.  20(3):163-71, 2001 Feb.

3287.      Lieber CS. Liver diseases by alcohol and hepatitis C: early detection and new insights in pathogenesis lead to improved treatment. [Review] [152 refs] American Journal on Addictions.  10 Suppl:29-50, 2001.

3288.      Mathur V K, Vyas P D. Hepatitis B vaccines: what is new. SDMH JI. 23(3), 6-10,1999.

3289.      Naik S R. Hepatitis B virus : Infected or just carrying. Indian J Gastroenterol. 19(3): 130-2, 2000.

3290.      Polywka S.  Schroter M. Feucht HH.  Zollner B. Laufs R. Relevance of reactivity in commercially available hepatitis C virus antibody assays. Journal of Clinical Microbiology.  39(4):1665-8, 2001 Apr.

3291.      Raina V. Purification and properties of recombinant hepatitis A 14s subunit protein. Proc natn Acad Sci India-Sect B.69(1): 27-36, 1999.

3292.      Rostaing L.  Borde JS. Hasle C.  Bories P.  Allal A. Abbal M.  Durand D.  Lack of effect of chronic hepatitis C virus infection on T-cell cytokine production in chronic hemodialysis patients. American Journal of Nephrology. 21(3):194-9, 2001 May-Jun.

3293.      Ryan M.  Desmond P. Liver toxicity. Could this be a drug reaction?. [Review] [8 refs] Australian Family Physician.  30(5):427-31, 2001 May.

3294.      Saab S.  Brezina M. Gitnick G.  Martin P. Yee HF Jr. Hepatitis C screening strategies in hemodialysis patients. [see comments]. American Journal of Kidney Diseases.  38(1):91-7, 2001 Jul.

3295.      Sagnelli E.  Coppola N. Scolastico C.  Mogavero AR.  Filippini P.  Piccinino F. HCV genotype and "silent" HBV coinfection: two main risk factors for a more severe liver disease. Journal of Medical Virology.  64(3):350-5, 2001 Jul.

3296.      Schroter M.  Schafer P. Zollner B.  Polywka S. Laufs R. Feucht HH.  Strategies for reliable diagnosis of hepatitis C infection: the need for a serological confirmatory assay. Journal of Medical Virology.  64(3):320-4, 2001 Jul.

3297.      Sheiner PA.  Florman SS. Emre S.  Fishbein T. Schwartz ME.  Miller CM.  Boros P. Recurrence of hepatitis C after liver transplantation is associated with increased systemic IL-10 levels. Mediators of Inflammation.  10(1):37-41, 2001 Feb.

3298.      Singh VK.  Naik S. Simultaneous amplification of DNA and RNA virus using multiplex PCR system. Clinica Chimica Acta. 308(1-2):179-81, 2001 Jun.

3299.      Smythe JS.  Anstee DJ. Expression of C antigen in transduced K562 cells. Transfusion. 41(1):24-30, 2001 Jan.

3300.            Sobao Y.  Tomiyama H.  Nakamura S.  Sekihara H. Tanaka K.  Takiguchi M.  Visual demonstration of hepatitis C virus-specific memory CD8(+) T-cell expansion in patients with acute hepatitis C.  Hepatology.  33(1):287-94, 2001 Jan.

3301.      Teixeira R.  Papatheodoridis GV.  Burroughs AK. Management of recurrent hepatitis C after liver transplantation. [Review] [88 refs]  Journal of Viral Hepatitis.  8(3):159-68, 2001 May.

3302.      Tennant BC.  Gerin JL. The woodchuck model of hepatitis B virus infection. [Review] [214 refs] Ilar Journal.  42(2):89-102, 2001.

3303.      Torre F.  Giusto R. Grasso A.  Brizzolara R.  Campo N. Sinelli N. Balestra V.  Picciotto A. Clearance kinetics of hepatitis C virus under different antiviral therapies. Journal of Medical Virology. 64(4):455-9, 2001 Aug.

3304.      Walsh K.  Alexander GJ.  Update on chronic viral hepatitis. [Review] [101 refs] Postgraduate Medical Journal. 77(910):498-505, 2001 Aug.

3305.      Wang QM.  Heinz BA. Recent advances in prevention and treatment of hepatitis C virus infections. [Review] [159 refs] Progress in Drug Research.  Spec No:79-110, 2001.

3306.      Weber B.  Melchior W. Gehrke R.  Doerr HW. Berger A. Rabenau H. Hepatitis B virus markers in anti-HBc only positive individuals. Journal of Medical Virology. 64(3):312-9, 2001 Jul.

3307.      Wendland BE.  Nutritional guidelines for persons infected with the hepatitis C virus: a review of the literature. [Review] [80 refs] Canadian Journal of Dietetic Practice & Research.  62(1):7-15, 2001 Spring.

3308.      Willers E. Webber L.  Delport R.  Kruger M. Hepatitis B--a major threat to childhood survivors of leukaemia/lymphoma. Journal of Tropical Pediatrics. 47(4):220-5, 2001 Aug.


Apr 02


4052.      Agarwal M K, Bhatt V B, Agrawal  A S : Hepatitis E. Gujarat med J 2000, 57(1), 21-3. (016248) Aug 16, 2023

4053.      Anand P, Thakur S K, Jaiprakash M, Sharma U K, Rajvanshi A, Gill H S, Narula A S: Hepatitis C in chronic renal failure and renal transplant recipents. Indain J Gastroenterl 1999, 18(1 Suppl), S35. (016255) Aug 16, 2023

4054.      Arora N K, Mathur P, Arora N,  Panda S K: Hepatitis C virus (HCV) infection in children in North India. Indian J Gastroenterol 1999,18(1 Suppl), S35. (016260) Aug 16, 2023

4055.      Arrankalle V A, Deshmukh T M, Chobe L P, Chadha M S, Walambe A M: Hepatitis G virus infection in India: prevalence and phylogenetic analysis based on 5’ non-coading region. Indian J Gastroenterol 2001,20(1), 13-17. (016259) Aug 16, 2023

4056.      Bapat S, Joshi D, Naik SS, Bavdekar A, Bhave S, Pandit A. Hepatitis B immunization in adolescent girls. Indian Pediatr  2001 Oct;38(10):1160-2

4057.      Bouchard MJ, Wang LH, Schneider RJ. Calcium signaling by HBx protein in hepatitis B virus DNA replication. Science  2001 Dec 14;294(5550):2376-8

4058.      Bruno R, Sacchi P, Malfitano A, Filice G. YMDD-mutant HBV strain as a cause of liver failure in an HIV-infected patient. Gastroenterology 2001 Oct;121(4):1027-8

4059.      Butz K, Denk C, Fitscher B, Crnkovic-Mertens I, Ullmann A, Schroder CH, Hoppe Seyler F. Peptide aptamers targeting the hepatitis B virus core protein: a new class of molecules with antiviral activity. Oncogene 2001 Oct 4;20(45):6579-86

4060.      Carroccio A, Giannitrapani L, Soresi M, Not T, Iacono G, Di Rosa C, Panfili E, Notarbartolo A, Montalto G. Guinea pig transglutaminase immunolinked assay does not predict coeliac disease in patients with chronic liver disease. Gut  2001 Oct;49(4):506-11

4061.      Chedid A, Sung CC, Lepe MR, Ahmed SA, Iftikhar SA, Feller A, Beaman KD. Expression of a novel protein by regenerating hepatocytes and peripheral blood lymphocytes. Clin Diagn Lab Immunol  2001 Nov;8(6):1292-4

4062.      Chen GG, Lai PB, Chak EC, Xu H, Lee KM, Lau WY. Immunohistochemical analysis of pro-apoptotic Bid level in chronic hepatitis, hepatocellular carcinoma and liver metastases. Cancer Lett  2001 Oct 22;172(1):75-82

4063.      Choudhuri G, Saraswat V A, Lakhtakia S, Dadhich S K, Mehrotra P, Naik S R: Poor response to low dose interferon therapy in chronic liver disease due to hepatitis B virus infection in Indian patients. Indian J Gastroenterol 1999, 18(1 Suppl), S26. (016288) Aug 16, 2023

4064.      Comanor L, Anderson F, Ghany M, Perrillo R, Heathcote EJ, Sherlock C, Zitron I, Hendricks D, Gordon SC. Transcription-mediated amplification is more sensitive than conventional PCR-based assays for detecting residual serum HCV RNA at end of treatment. Am J Gastroenterol  2001 Oct;96(10):2968-72

4065.      Crespo J, Cayon A, Fernandez-Gil P, Hernandez-Guerra M, Mayorga M, Dominguez Diez A, Fernandez-Escalante JC, Pons-Romero F. Gene expression of tumor necrosis factor alpha and TNF-receptors, p55 and p75, in nonalcoholic steatohepatitis patients. Hepatology  2001 Dec;34(6):1158-63

4066.      Davis GL. Treatment of chronic hepatitis C. BMJ 2001 Nov 17;323(7322):1141-2

4067.      De Silvestri A, Pasi A, Martinetti M, Belloni C, Tinelli C, Rondini G, Salvaneschi L, Cuccia M. Family study of non-responsiveness to hepatitis B vaccine confirms the importance of HLA class III C4A locus. Genes Immun  2001 Nov;2(7):367-72

4068.      Faustini A, Spadea T, Fano V, Giorgi Rossi P, Sangalli M, Franco E, Perucci CA. Factors associated with hepatitis B virus immunization coverage at the beginning of a population campaign in the Lazio region, Italy. Prev Med  2001 Nov;33(5):409-14

4069.      Friebe P, Lohmann V, Krieger N, Bartenschlager R. Sequences in the 5' nontranslated region of hepatitis C virus required for RNA replication. J Virol 2001 Dec;75(24):12047-57

4070.      Goddard S, Williams A, Morland C, Qin S, Gladue R, Hubscher SG, Adams DH. Differential expression of chemokines and chemokine receptors shapes the inflammatory response in rejecting human liver transplants. Transplantation 2001 Dec 27;72(12):1957-67

4071.      Govindarajan  R, Naik S: Modulation of tumor necrosis factor-a production by hepatitis B virus in human monocytic cell line, THP-1. Indian J Gastroenterol 1999, 18(1 Suppl), S22. (016330) Aug 16, 2023

4072.      Greenberg DP. Considerations for hepatitis B as part of a combination vaccine. Pediatr Infect Dis J  2001 Nov;20(11 Suppl):S34-9

4073.      Gupta DK, Charles AR, Srinivas M, Dave S, Bal CS. Betamethasone in plus phenobarbitone prior to hepatobiliary scintigraphy increases diagnostic accuracy in infants with jaundice. Indian J Pediatr  2001 Nov;68(11):1039-41

4074.      Harjeet Singh, Pradhan M, Naik S: Antibody response to hepatitis B vaccine in thalassemic children. Indian J Gastroenterol 1999, 18(1 Suppl), S22. (016341) Aug 16, 2023

4075.      Jacobs RJ, Meyerhoff AS. Comparative cost effectiveness of varicella, hepatitis A, and pneumococcal conjugate vaccines. Prev Med 2001 Dec;33(6):639-45

4076.      Jaiswal S P, Chitnis D S, Naik G, Jain A, Salgia P, Sepaha A: Hepatitis B and Cvirus scenario in central India. Indian J Gastroenterol 1999, 18(1 Suppl), S38-40. (016350) Aug 16, 2023

4077.      Jhamb U, Malhotra V, Mittal S K: Hepatitis B and C in childhood chronic liver disease. Indian J Gastroenterol 1999, 18(1 Suppl), S40. (016355) Aug 16, 2001

4078.      Jolivet-Reynaud C, Lesenechal M, O'Donnell B, Becquart L, Foussadier A, Forge F, Battail-Poirot N, Lacoux X, Carman W, Jolivet M. Localization of hepatitis B surface antigen epitopes present on variants and specifically recognised by anti-hepatitis B surface antigen monoclonal antibodies. J Med Virol 2001 Oct;65(2):241-9

4079.      Joshi N, Ajit Kumar, Rao N, Girish Narayan M, Nagarjun Kumar Y R, Babu S: Efficacy of the 1st indigenously developed recombinant vaccine against hepatitis B virus in Indian subjects. Indian J Gastroenterol 1999, 18(1 Suppl), S24-5.(016356) Aug 16, 2023

4080.      Kato H, Orito E, Sugauchi F, Ueda R, Gish RG, Usuda S, Miyakawa Y, Mizokami M. Determination of hepatitis B virus genotype G by polymerase chain reaction with hemi-nested primers. J Virol Methods 2001 Nov;98(2):153-9

4081.      Kuffner EK, Dart RC, Bogdan GM, Hill RE, Casper E, Darton L. Effect of maximal daily doses of acetaminophen on the liver of alcoholic patients: a randomized, double-blind, placebo-controlled trial. Arch Intern Med 2001 Oct 8;161(18):2247-52

4082.      Li C, Candotti D, Allain JP. Production and characterization of monoclonal antibodies specific for a conserved epitope within hepatitis C virus hypervariable region 1. J Virol  2001 Dec;75(24):12412-20

4083.      Li D, Mallory T, Satomura S. AFP-L3: a new generation of tumor marker for hepatocellular carcinoma. Clin Chim Acta 2001 Nov;313(1-2):15-9

4084.      Lieber CS. Alcoholic liver injury: pathogenesis and therapy in 2001. Pathol Biol (Paris)  2001 Nov;49(9):738-52

4085.      Madan K, Jain A, Jandwani P, Gupta R K, Kar P, Mathur U S: Multicentric open labelled evaluation of immunogenicity (seroprotection rate) and reactogenicity of a recombinant DNA hepatitis B vaccine of Cuban origin when administered in a two dose schedule. Indian J Gastroenterol 1999, 18(1 Suppl),S24. ) (016378) Aug 16, 2023

4086.      Mathur P, Arora N K: Consideration for HAV vaccine in India. Indian J Pediat 2001, 68(1),23-30. (016392) Aug 16, 2023

4087.      Mawhorter SD. Who should receive hepatitis A vaccine? Cleve Clin J Med  2001 Oct;68(10):825-7

4088.      Mele A, Tancredi F, Romano L, Giuseppone A, Colucci M, Sangiuolo A, Lecce R, Adamo B, Tosti ME, Taliani G, Zanetti AR. Effectiveness of hepatitis B vaccination in babies born to hepatitis B surface antigen-positive mothers in Italy. J Infect Dis  2001 Oct 1;184(7):905-8

4089.      Mittal S K: Desirability and fesibility of hepatitis B vaccine in EPI. Indian J Pediat 2001, 68(1), 61-5. (016400) (No abstract) Aug 16, 2023

4090.      Nair S, Perrillo RP. Serum alanine aminotransferase flares during interferon treatment of chronic hepatitis B: is sustained clearance of HBV DNA dependent on levels of pretreatment viremia? Hepatology 2001 Nov;34(5):1021-6

4091.      Rajan S, Liebman HA. Treatment of hepatitis C related thrombocytopenia with interferon alpha. Am J Hematol  2001 Nov;68(3):202-9

4092.      Ray S, Broor S, Ghosh D, Vaisnav Y, Broor S L, Dar L, Seth P: TGF b levels in HCV related chronic liver disease as studied by semiquantitative RT-PCR. Indian J Gastroenterol 1999, 18(1 Suppl), S33. (016455) Aug 16, 2023

4093.      Sewell EC, Jacobson SH, Weniger BG. "Reverse engineering" a formulary selection algorithm to determine the economic value of pentavalent and hexavalent combination vaccines. Pediatr Infect Dis J  2001 Nov;20(11 Suppl):S45-56

4094.      Sleijffers A, Garssen J, de Gruijl FR, Boland GJ, van Hattum J, van Vloten WA, van Loveren H. Influence of ultraviolet B exposure on immune responses following hepatitis B vaccination in human volunteers. J Invest Dermatol  2001 Nov;117(5):1144-50

4095.      Thakur S K, Gupta R M, Rao M K K, Dham S K: Hepatitis B carrier-a study of possible routes of acquiring the infection. Indian J Gastroenterol 1999, 18(1 Suppl), S23. (016520) Aug 16, 2023

4096.      Torre D, Tambini R, Cadario F, Barbarini G, Moroni M, Basilico C. Evolution of coinfection with human immunodeficiency virus and hepatitis C virus in patients treated with highly active antiretroviral therapy. Clin Infect Dis  2001 Nov 1;33(9):1579-85

4097.      Webster G, Bertoletti A. Quantity and quality of virus-specific CD8 cell response: relevance to the design of a therapeutic vaccine for chronic HBV infection. Mol Immunol  2001 Dec;38(6):467-73

4098.      Zimet GD, Kee R, Winston Y, Perkins SM, Maharry K. Acceptance of hepatitis B vaccination among adult patients with sexually transmitted diseases. Sex Transm Dis  2001 Nov;28(11):678-80

4099.      Zmuda JF, Wagoneer B, Liotta L, Whiteley G. Recognition of multiple classes of hepatitis C antibodies increases detection sensitivity in oral fluid. Clin Diagn Lab Immunol  2001 Nov;8(6):1267-70

4100.      Zuckerman JN, Zuckerman AJ, Symington I, Du W, Williams A, Dickson B, Young MD; UK Hepacare Study Group. Evaluation of a new hepatitis B triple-antigen vaccine in inadequate responders to current vaccines. Hepatology  2001 Oct;34(4 Pt 1):798-802

July 02


4608.      Aceti A, Pasquazzi C, Zechini B, De Bac C. Hepatotoxicity development during antiretroviral therapy containing protease inhibitors in patients with HIV: the role of hepatitis B and C virus infection. J Acquir Immune Defic Syndr. 2002 Jan 1;29(1):41-8.

4609.      Almroth G, Ekermo B, Mansson AS, Svensson G, Widell A. Detection and prevention of hepatitis C in dialysis patients and renal transplant recipients. A long-term follow up (1989-January 1997). J Intern Med. 2002 Feb;251(2):119-28.

4610.      Alzahrani AJ, Vallely PJ, McMahon RF. Development of a novel nested in situ PCR-ISH method for detection of hepatitis C virus RNA in liver tissue. J Virol Methods. 2002 Jan;99(1-2):53-61.

4611.      Angelico M, Di Paolo D, Trinito MO, Petrolati A, Araco A, Zazza S, Lionetti R, Casciani CU, Tisone G.  Failure of a reinforced triple course of hepatitis B vaccination in patients transplanted for HBV-related cirrhosis. Hepatology. 2002 Jan;35(1):176-81.

4612.      Aoki M, Saito T, Watanabe H, Matsuo T, Saito K, Togashi H, Kawata S, Ishikawa K, Aoyama M, Kamada H, Shinzawa H. Clinical significance of a highly sensitive enzyme immunoassay of hepatitis B surface antigen using a novel electron spin resonance technique. J Med Virol. 2002 Feb;66(2):166-70.

4613.      Bernstein D, Kleinman L, Barker CM, Revicki DA, Green J. Relationship of health-related quality of life to treatment adherence and sustained response in chronic hepatitis C patients. Hepatology. 2002 Mar;35(3):704-8.

4614.      Bluteau O, Beaudoin JC, Pasturaud P, Belghiti J, Franco D, Bioulac-Sage P, Laurent-Puig P, Zucman-Rossi J. Specific association between alcohol intake, high grade of differentiation and 4q34-q35 deletions in hepatocellular carcinomas identified by high resolution allelotyping. Oncogene. 2002 Feb 14;21(8):1225-32.

4615.      Bonaccorso S, Marino V, Puzella A, Pasquini M, Biondi M, Artini M, Almerighi C, Verkerk R, Meltzer H, Maes M. Increased depressive ratings in patients with hepatitis C receiving interferon-alpha-based immunotherapy are related to interferon-alpha-induced changes in the serotonergic system. J Clin Psychopharmacol. 2002 Feb;22(1):86-90.

4616.      Bonkovsky HL. Iron as a comorbid factor in chronic viral hepatitis. Am J Gastroenterol. 2002 Jan;97(1):1-4.

4617.      Brinster C, Chen M, Boucreux D, Paranhos-Baccala G, Liljestrom P, Lemmonier F, Inchauspe G. Hepatitis C virus non-structural protein 3-specific cellular immune responses following single or combined immunization with DNA or recombinant Semliki Forest virus particles. J Gen Virol. 2002 Feb;83(Pt 2):369-81.

4618.      Buchanan D, Khoshnood K, Stopka T, Shaw S, Santelices C, Singer M. Ethical dilemmas created by the criminalization of status behaviors: case examples from ethnographic field research with injection drug users. Health Educ Behav. 2002 Feb;29(1):30-42.

4619.      Cardin R, D'Errico A, Fiorentino M, Cecchetto A, Naccarato R, Farinati F.  Hepatocyte proliferation and apoptosis in relation to oxidative damage in aalcohol-related liver disease Alcohol Alcohol. 2002 Jan-Feb;37(1):43-8.

4620.      Carvajal GP, Garcia D, Sanchez SA, Velasco MA, Rueda D, Lucena MI. Hepatotoxicity associated with the new antidepressants. J Clin Psychiatry. 2002 Feb;63(2):135-7.

4621.      Chamberland ME. Emerging infectious agents: do they pose a risk to the safety of transfused blood and blood products? Clin Infect Dis. 2002 Mar 15;34(6):797-805.

4622.      Chan HL. Changing scene in hepatitis B serology interpretation. Hosp Med. 2002 Jan;63(1):16-9. Review.

4623.      Chitturi S, Abeygunasekera S, Farrell GC, Holmes-Walker J, Hui JM, Fung C, Karim R, Lin R, Samarasinghe D, Liddle C, Weltman M, George J. NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome. Hepatology. 2002 Feb;35(2):373-9.

4624.      Cody SH, Nainan OV, Garfein RS, Meyers H, Bell BP, Shapiro CN, Meeks EL, Pitt H, Mouzin E, Alter MJ, Margolis HS, Vugia DJ. Hepatitis C virus transmission from an anesthesiologist to a patient. Arch Intern Med. 2002 Feb 11;162(3):345-50.

4625.      Czaja AJ, Donaldson PT, Lohse AW. Antibodies to soluble liver antigen/liver pancreas and HLA risk factors for type 1 autoimmune hepatitis. Am J Gastroenterol. 2002 Feb;97(2):413-9.

4626.      Dai CY, Yu ML, Chuang WL, Hou NJ, Hou C, Chen SC, Lin ZY, Hsieh MY, Wang LY, Chang WY.  The response of hepatitis C virus and TT virus to high dose and long duration interferon-alpha therapy in naive chronic hepatitis C patients. Antiviral Res. 2002 Jan;53(1):9-18.

4627.      Dandri M, Burda MR, Burkle A, Zuckerman DM, Will H, Rogler CE, Greten H, Petersen J. Increase in de novo HBV DNA integrations in response to oxidative DNA damage or inhibition of poly(ADP-ribosyl)ation. Hepatology. 2002 Jan;35(1):217-23.

4628.      Di Bisceglie AM, McHutchison J, Rice CM. New therapeutic strategies for hepatitis C. Hepatology. 2002 Jan;35(1):224-31. Review.

4629.      Edstam JS, Dulmaa N, Nymadawa P, Rinchin A, Khulan J, Kimball AM. Comparison of hepatitis B vaccine coverage and effectiveness among urban and rural Mongolian 2-year-olds. Prev Med. 2002 Feb;34(2):207-14.

4630.      Fong TL, Bunnapradist S, Jordan SC, Cho YW. Impact of hepatitis B core antibody status on outcomes of cadaveric renal transplantation: analysis of United network of organ sharing database between 1994 and 1999. Transplantation. 2002 Jan 15;73(1):85-9.

4631.      Frese M, Schwarzle V, Barth K, Krieger N, Lohmann V, Mihm S, Haller O, Bartenschlager R. Interferon-gamma inhibits replication of subgenomic and genomic hepatitis C virus RNAs. Hepatology. 2002 Mar;35(3):694-703.

4632.      Furusyo N, Hayashi J, Kashiwagi K, Nakashima H, Nabeshima S, Sawayama Y, Kinukawa N, Kashiwagi S. Hepatitis C virus (HCV) RNA level determined by second-generation branched-DNA probe assay as predictor of response to interferon treatment in patients with chronic HCV viremia. Dig Dis Sci. 2002 Mar;47(3):535-42.

4633.      Galun E, Eren R, Safadi R, Ashour Y, Terrault N, Keeffe EB, Matot E, Mizrachi S, Terkieltaub D, Zohar M, Lubin I, Gopher J, Shouval D, Dagan S.  Clinical evaluation (phase I) of a combination of two human monoclonal antibodies to HBV: safety and antiviral properties. Hepatology. 2002 Mar;35(3):673-9.

4634.      Garcia-Retortillo M, Forns X, Feliu A, Moitinho E, Costa J, Navasa M, Rimola A, Rodes J.  Hepatitis C virus kinetics during and immediately after liver transplantation. Hepatology. 2002 Mar;35(3):680-7.

4635.      Goswami BB, Kulka M, Ngo D, Istafanos P, Cebula TA. A polymerase chain reaction-based method for the detection of hepatitis A virus in produce and shellfish. J Food Prot. 2002 Feb;65(2):393-402.

4636.      Grant MD. Antibody convergence along a common idiotypic axis in immunodeficiency virus and hepatitis C virus infections. J Med Virol. 2002 Jan;66(1):13-21.

4637.      Green ST, Kinghorn GR, Goldberg DJ, Mohsen AH. The value of genitourinary medicine clinics in the recognition and diagnosis of new cases of hepatitis C in the United Kingdom. Int J STD AIDS. 2002 Jan;13(1):60-2.

4638.      Harris HE, Ramsay ME, Andrews N, Eldridge KP. Clinical course of hepatitis C virus during the first decade of infection: cohort study. BMJ. 2002 Feb 23;324(7335):450-3.

4639.      Hino K, Basuni AA, Ireland J, Newell A, Mphahlele J, Smit EJ, Ngui SL, Teo CG, Carman WF. Reappearance of hepatitis B surface antigen in immunocompromised individuals: reinfection or reactivation? Dig Dis Sci. 2002 Feb;47(2):415-8.

4640.      Idilman R, De MN, Colantoni A, Nadir A, Van T. The effect of high dose and short interval HBV vaccination in individuals with chronic hepatitis C. Am J Gastroenterol. 2002 Feb;97(2):435-9.

4641.      Iino S. Natural history of hepatitis B and C virus infections. Oncology. 2002;62 Suppl 1:18-23. Review.

4642.      Jacobs RJ, Koff RS, Meyerhoff AS. The cost-effectiveness of vaccinating chronic hepatitis C patients against hepatitis A. Am J Gastroenterol. 2002 Feb;97(2):427-34.

4643.      Joshi S, Cauch-Dudek K, Wanless IR, Lindor KD, Jorgensen R, Batts K, Heathcote EJ. Primary biliary cirrhosis with additional features of autoimmune hepatitis: response to therapy with ursodeoxycholic acid. Hepatology. 2002 Feb;35(2):409  13.

4644.      Jung MC, Pape GR. Immunology of hepatitis B infection. Lancet Infect Dis. 2002 Jan;2(1):43-50. Review.

4645.      King MD, Reznik DA, O'Daniels CM, Larsen NM, Osterholt D, Blumberg HM. Human papillomavirus-associated oral warts among human immunodeficiency virus-seropositive patients in the era of highly active antiretroviral therapy: an emerging infection. Clin Infect Dis. 2002 Mar 1;34(5):641-8.

4646.      Lai MM. Hepatitis C virus proteins: direct link to hepatic oxidative stress, steatosis, carcinogenesis and more. Gastroenterology. 2002 Feb;122(2):568-71. Review.

4647.      Lankarani KB, Taghavi AR, Agah S, Karimi A. Comparison of intradermal and intramuscular administration of hepatitis B vaccine in neonates. Indian J Gastroenterol 2001, 20(3), 94-6.

4648.      Laskus T, Radkowski M, Wilkinson J, Vargas H, Rakela J. The origin of hepatitis C virus reinfecting transplanted livers: serum-derived versus peripheral blood mononuclear cell-derived virus. J Infect Dis. 2002 Feb 15;185(4):417-21.

4649.      Latorre P, Rubbia-Brandt L, Giostra E, Abid K, Negro F. The 4,977-base pair common deletion of mitochondrial DNA is not associated with steatosis in chronic hepatitis C patients. Hepatology. 2002 Jan;35(1):239-40.

4650.      Lau D. Therapy of chronic Hepatitis B. Gastroenterol Today 2000, 4(4), 172.

4651.      Lauer GM, Nguyen TN, Day CL, Robbins GK, Flynn T, McGowan K, Rosenberg ES, Lucas M, Klenerman P, Chung RT, Walker BD.  Human immunodeficiency virus type 1-hepatitis C virus coinfection: intraindividual comparison of cellular immune responses against two persistent viruses. J Virol. 2002 Mar;76(6):2817-26.

4652.      Levy S, Herve C, Delacoux E, Erlinger S. Thiamine deficiency in hepatitis C virus and alcohol-related liver diseases. Dig Dis Sci. 2002 Mar;47(3):543-8.

4653.      Macalalad AR, Snydman DR. GB virus C and mortality from HIV infection. N Engl J Med. 2002 Jan 31;346(5):377-9.

4654.      Madison DL, Allen E, Deodhar A, Morrison L. Henoch-Schonlein purpura: a possible complication of hepatitis C related liver cirrhosis. Ann Rheum Dis. 2002 Mar;61(3):281-2. Review.

4655.      Maguire D, Heaton ND, Smith HM. Failure of reactivation of hepatitis B after liver transplantation in hepatitis B surface antigen-negative, core antibody-positive recipients. Transplantation. 2002 Feb 15;73(3):481-2.

4656.      Mishra D, Singh R, Sibal A. Liver transplantation for fulminant hepatitis A infection. Indian Pediatr. 2002 Feb;39(2):189-92.

4657.      Mistry SK, Burwell TJ, Chambers RM, Rudolph-Owen L, Spaltmann F, Cook WJ, Morris SM Jr. Cloning of human agmatinase. An alternate path for polyamine synthesis induced in liver by hepatitis B virus. Am J Physiol Gastrointest Liver Physiol. 2002 Feb;282(2):G375-81.

4658.      Murrill CS, Weeks H, Castrucci BC, Weinstock HS, Bell BP, Spruill C, Gwinn M. Age-specific seroprevalence of HIV, hepatitis B virus, and hepatitis C virus infection among injection drug users admitted to drug treatment in 6 US cities. Am J Public Health. 2002 Mar;92(3):385-7.

4659.      Mutimer D. Positive suggestions about the anti-HBc positive donor. Gut. 2002 Jan;50(1):7-8.

4660.      Nelson DB. Effectiveness of manual cleaning and disinfection for the elimination of hepatitis C virus from GI endoscopes. Am J Gastroenterol. 2002 Jan;97(1):204-6.

4661.      Novel ring-expanded nucleoside analogs exhibit potent and selective inhibition of hepatitis B virus replication in cultured human hepatoblastoma cells. Antiviral Res. 2002 Feb;53(2):159-64.

4662.      Okuda M, Li K, Beard MR, Showalter LA, Scholle F, Lemon SM, Weinman SA. Mitochondrial injury, oxidative stress, and antioxidant gene expression are induced by hepatitis C virus core protein. Gastroenterology. 2002 Feb;122(2):366-75.

4663.      Pandey CK, Singh N, Kumar V, Agarwal A, Singh PK. Typhoid, hepatitis E, or typhoid and hepatitis E: the cause of fulminant hepatic failure--a diagnostic dilemma. Crit Care Med. 2002 Feb;30(2):376-8.

4664.      Pennesi M, Torre G, Del Santo M, Sonzogni A. Glomerulonephritis after recombinant hepatitis B vaccine. Pediatr Infect Dis J. 2002 Feb;21(2):172-3.

4665.      Persico M, De Marino F, Russo GD, Morante A, Rotoli B, Torella R, De Renzo A.  Efficacy of lamivudine to prevent hepatitis reactivation in hepatitis B virus-infected patients treated for non-Hodgkin lymphoma. Blood. 2002 Jan 15;99(2):724-5.

4666.      Podzorski RP. Molecular testing in the diagnosis and management of hepatitis C virus infection. Arch Pathol Lab Med. 2002 Mar;126(3):285-90. Review.

4667.      Quadri R, Giostra E, Roskams T, Pawlotsky JM, Mentha G, Rubbia-Brandt L, Perrin L, Hadengue A, Negro F.  Immunological and virological effects of ribavirin in hepatitis C after liver transplantation. Transplantation. 2002 Feb 15;73(3):373-8.

4668.      Renge RL, Dani VS, Chitambar SD, Arankalle VA. Fulminant hepatitis A in children with sickle cell disease. Indian Pediatr. 2002 Feb;39(2):186-9.

4669.      Romero MA, Seoane J, Varela-Centelles P, Diz-Dios P, Otero XL. Clinical and pathological characteristics of oral lichen planus in hepatitis C-positive and  negative patients. Clin Otolaryngol. 2002 Feb;27(1):22-6.

4670.      Roque-Afonso AM, Feray C, Samuel D, Simoneau D, Roche B, Emile JF, Gigou M, Shouval D, Dussaix E. Antibodies to hepatitis B surface antigen prevent viral reactivation in recipients of liver grafts from anti-HBC positive donors. Gut. 2002 Jan;50(1):95-9.

4671.      Rosenberg PM, Farrell JJ, Abraczinskas DR, Graeme-Cook FM, Dienstag JL, Chung RT.  Rapidly progressive fibrosing cholestatic hepatitis--hepatitis C virus in HIV coinfection. Am J Gastroenterol. 2002 Feb;97(2):478-83.

4672.      Sarmiento OL, Ford CL, Newbern EC, Miller WC, Poole C, Kaufman JS. The importance of assessing effect modification when asserting racial differences in associations between human leukocyte antigen class II alleles and hepatitis C virus outcomes. J Infect Dis. 2002 Jan 15;185(2):266-8.

4673.      Schlaak JF, Schramm C, Radecke K, zum Buschenfelde KH, Gerken G.  Sustained suppression of HCV replication and inflammatory activity after interleukin-2 therapy in patients with HIV/hepatitis C virus coinfection. J Acquir Immune Defic Syndr. 2002 Feb 1;29(2):145-8.

4674.      Sherman KE, Rouster SD, Chung RT, Rajicic N. Hepatitis C Virus prevalence among patients infected with Human Immunodeficiency Virus: a cross-sectional analysis of the US adult AIDS Clinical Trials Group. Clin Infect Dis. 2002 Mar 15;34(6):831-7.

4675.      Shirin H, Davidovitz Y, Avni Y, Petchenko P, Krepel Z, Bruck R, Meytes D.  Prevalence of hepatitis C virus infection in patients with lymphoproliferative disorders. Isr Med Assoc J. 2002 Jan;4(1):24-7.

4676.      Singh S K, Aggarwal A. Hepatitis B – one step ahead over AIDS. Antiseptic, Madurai 2001, 98(7), 270-5.

4677.      Stein K, Rosenberg W, Wong J. Cost effectiveness of combination therapy for hepatitis C: a decision analytic model. Gut. 2002 Feb;50(2):253-8.

4678.      Sulkowski MS, Thomas DL, Mehta SH, Chaisson RE, Moore RD. Hepatotoxicity associated with nevirapine or efavirenz-containing antiretroviral therapy: role of hepatitis C and B infections. Hepatology. 2002 Jan;35(1):182-9.

4679.      Thibault V, Aubron-Olivier C, Agut H, Katlama C. Primary infection with a lamivudine-resistant hepatitis B virus. AIDS. 2002 Jan 4;16(1):131-3.

4680.      Thibault V, Candotti D, Autran B, Cahour A, Agut H. Hepatitis C virus infection in long-term nonprogressor HIV-1-infected subjects. J Acquir Immune Defic Syndr. 2002 Feb 1;29(2):204-6.

4681.      Torti C, Patroni A, Tinelli C, Sleiman I, Quiros-Roldan E, Puoti M, Castelli F.  Influence of hepatitis C virus coinfection on lipid abnormalities in HIV-positive patients after highly active antiretroviral therapy. J Acquir Immune Defic Syndr. 2002 Mar 1;29(3):315-7.

4682.      van Steenbergen JE, Niesters HG, Op de Coul EL, van Doornum GJ, Osterhaus AD, Leentvaar-Kuijpers A, Coutinho RA, van den Hoek JA. Molecular epidemiology of hepatitis B virus in Amsterdam 1992-1997. J Med Virol. 2002 Feb;66(2):159-65.

4683.      Vardas E, Ross MH, Sharp G, McAnerney J, Sim J. Viral hepatitis in South African healthcare workers at increased risk of occupational exposure to blood-borne viruses. J Hosp Infect. 2002 Jan;50(1):6-12.

4684.      Vargas HE, Dodson FS, Rakela J. A concise update on the status of liver transplantation for hepatitis B virus: the challenges in 2002. Liver Transpl. 2002 Jan;8(1):2-9. Review.

4685.      Vertuani S, Bazzaro M, Gualandi G, Micheletti F, Marastoni M, Fortini C, Canella A, Marino M, Tomatis R, Traniello S, Gavioli R. Effect of interferon-alpha therapy on epitope-specific cytotoxic T lymphocyte responses in hepatitis C virus-infected individuals. Eur J Immunol. 2002 Jan;32(1):144-54.

4686.      Vohra P. Chronic viral hepatitis and its management in children. Paediat Today 2001, 4(2), 70-80.JBT

4687.      Waris G, Siddiqui A. Interaction between STAT-3 and HNF-3 leads to the activation of liver-specific hepatitis B virus enhancer 1 function. J Virol. 2002 Mar;76(6):2721-9.

4688.      Zylberberg H, Nalpas B, Carnot F, Skhiri H, Fontaine H, Legendre C, Kreis H, Brechot C, Pol S. Severe evolution of chronic hepatitis C in renal transplantation: a case control study. Nephrol Dial Transplant. 2002 Jan;17(1):129-33.


Oct 02


5354.      Ali G, Kumar M, Bali SK, Wadhwa WB, Hepatitis E associated immune thrombocytopaenia and membranous glomerulonephritis. Indian J Nephrol. 2001; 11(2), 70-2.

5355.      Anselmo DM, Ghobrial RM, Jung LC, Weaver M, Cao C, Saab S, Kunder G, Chen PW, Farmer DG, Yersiz H, Baquerizo A, Geevarghese S, Han SH, Goldstein L, Holt CD, Gornbein JA, Busuttil RW. New era of liver transplantation for hepatitis B: a 17-year single-center experience. Ann Surg. 2002 May;235(5):611-9; discussion 619-20.

5356.      Armstrong GL, Bell BP. Hepatitis A virus infections in the United States: model-based estimates and implications for childhood immunization. Pediatrics. 2002 May;109(5):839-45.

5357.      Arthur MJ. Reversibility of liver fibrosis and cirrhosis following treatment for hepatitis C. Gastroenterology. 2002 May;122(5):1525-8.

5358.      Bhaskara Rao PVR. Hepatitis-B vaccineall don’t need it. Homeopathic Prestige. 2001; 17(8), 369-74.

5359.      Carpenter PA, Huang ML, McDonald GB. Activation of occult hepatitis B from a seronegative patient after hematopoietic cell transplant: a cautionary tale. Blood. 2002 Jun 1;99(11):4245-6.

5360.      Chandra s, Gupta CP. Antibacterial activity of medicinal plant Crateava nurvala (bark) against bacterial strains causing urinary tract infection. Asian J chem. 2001; 13(3), 1181-6.

5361.      Chatterjee C, Mitra K, Hazra SC, Banerjee D, Guha SK, Neogi DK. Prevention of HCV infection among patient of chronic active hepatitis and cirrhosis cases in Calcutta. Indian J Med Microbiol. 2001; 19(1), 46-7.

5362.      Chern JP, Lin KH. Hypoparathyroidism in transfusion-dependent patients with beta-thalassemia. J Pediatr Hematol Oncol. 2002 May;24(4):291-3.

5363.      Chu CJ, Lok AS. Clinical significance of hepatitis B virus genotypes. Hepatology. 2002 May;35(5):1274-6. Review.

5364.      Day CP.  Non-alcoholic steatohepatitis (NASH): where are we now and where are we going? Gut. 2002 May;50(5):585-8. Review.

5365.      Desai I, Aligetti M. Hepatitis G. Indian J Occup Hlth. 2001; 44(1), 30-1.

5366.      Dutta AK. IAP hepatitis B immunization schedule. Indian Pediat. 2001; 38(11), 1335-8.

5367.      Elliott JH, Kunze M, Torresi J. Hepatitis A vaccine failure. Lancet. 2002 Jun 1;359(9321):1948-9.

5368.      El-Serag HB, Everhart JE. Diabetes increases the risk of acute hepatic failure. Gastroenterology. 2002 Jun;122(7):1822-8.

5369.      Enomoto M, Nishiguchi S. SEN viruses and treatment response in chronic hepatitis C virus. Lancet. 2002 May 18;359(9319):1780-1.

5370.      Feitelson MA, Sun B, Satiroglu Tufan NL, Liu J, Pan J, Lian Z. Genetic mechanisms of hepatocarcinogenesis. Oncogene. 2002 Apr 11;21(16):2593-604. Review.

5371.      Gollar R. Studies on efficacy of ribozymes and DNA enzymes against X gene of Hepatitis B Virus and HIV coreceptor CCR5. Department of Immunology, Jawaharlal Nehru University, New Delhi. 2001.

5372.      Grant M. Secondary persistent infection with hepatitis C virus: a challenge for adaptive immunity. Lancet. 2002 Apr 27;359(9316):1452.

5373.      Guido M, Fagiuoli S, Tessari G, Burra P, Leandro G, Boccagni P, Cillo U, Naccarato R, Rugge M.  Histology predicts cirrhotic evolution of post transplant hepatitis C. Gut. 2002 May;50(5):697-700.

5374.      Guptan RC, Thakur V, Malhotra V, Sarin SK. Recombinant interferon therapy in Indian children with HBV related chronic liver disease. Indian Pediatr. 2002 May;39(5):462-7.

5375.      Heathcote EJ. Overlap of autoimmune hepatitis and primary biliary cirrhosis: an evaluation of a modified scoring system. Am J Gastroenterol. 2002 May;97(5):1090-2.

5376.      Irnich D et.al. Randomised trial of acupuncture compared with conventional massage and “sham” laser acupuncture for treatment of chronic neck pain. Selections BMJ – South Asia Edn. 2001; 17(7), 604-7.

5377.      Jacob John T, Abraham P. Hepatitis B in India: a review of disease epidemiology. Indian Pediat. 2001; 38(11), 1318-25.

5378.      Kelly D, Skidmore S. Hepatitis C-Z: recent advances. Arch Dis Child. 2002 May;86(5):339-43. Review.

5379.      Lee PC, Hung CJ, Lin YJ, Wang JR, Jan MS, Lei HY. A role for chronic parvovirus B19 infection in liver dysfunction in renal transplant recipients? Transplantation. 2002 May 27;73(10):1635-9.

5380.      Liaw YF. Chronic hepatitis B guidelines: east versus west. Hepatology. 2002 Apr;35(4):979-81; discussion 981-2.

5381.      Malik AS. Complications of bacteriologically confirmed typhoid fever in children. J Trop Pediatr. 2002 Apr;48(2):102-8.

5382.      Miedouge M, Chatelut M, Mansuy JM, Rostaing L, Malecaze F, Sandres-Saune K, Boudet F, Puel J, Abbal M, Izopet J. Screening of blood from potential organ and cornea donors for viruses. J Med Virol  2002 Apr;66(4):571-5

5383.      Muir AJ, Rockey DC. Acute HCV: the early bird catches the virus. Gastroenterology. 2002 Apr;122(4):1176-7; discussion 1177-8.

5384.      Nafeesa F. Incidence of hepatitis C virus infection in alcoholic, post transfusion and renal transplant subjects. Department of Microbiology, Osmania University ; Hyderabad, 2001.

5385.      Pawlotsky JM. Molecular diagnosis of viral hepatitis. Gastroenterology. 2002 May;122(6):1554-68. Review.

5386.      Sanchez-Lombrana JL, Alvarez RP, Saez LR, Oliva NP, Martinez RM. Acute hepatitis associated with cetirizine intake. J Clin Gastroenterol. 2002 Apr;34(4):493-5.

5387.      Stewart DE. Hepatic adverse reactions associated with nefazodone. Can J Psychiatry. 2002 May;47(4):375-7.

5388.      Usuki N, Miyamoto T.  Chronic hepatic disease: usefulness of serial CT examinations. J Comput Assist Tomogr. 2002 May-Jun;26(3):418-21.

5389.      Vassileva ANA. Strategies for optimisation of Hepatitis B surface antigen in Picha Pastoris. Department of Biochemistry, University of Mysore, Mysore; 2001

5390.      Xu DZ, Yan YP, Choi BC, Xu JQ, Men K, Zhang JX, Liu ZH, Wang FS. Risk factors and mechanism of transplacental transmission of hepatitis B virus: a case-control study. J Med Virol. 2002 May;67(1):20-6.

5391.      Younossi ZM, Diehl AM, Ong JP. Nonalcoholic fatty liver disease: an agenda for clinical research. Hepatology. 2002 Apr;35(4):746-52. Review.



5392.      Campo JV, McNabb J, Perel JM, Mazariegos GV, Hasegawa SL, Reyes J. Kava-induced fulminant hepatic failure. J Am Acad Child Adolesc Psychiatry. 2002 Jun;41(6):631-2.

5393.      Carmichael M. Risking life to give life. Newsweek. 2002 Apr 22;139(16):53.

5394.      Castellote J, Gornals J, Lopez C, Xiol X. Acute tension hydrothorax: a life-threatening complication of cirrhosis. J Clin Gastroenterol. 2002 May-Jun;34(5):588-9.

5395.      Chang MH.  Viral mutants and fulminant hepatitis. A dominant hepatitis B virus population defective in virus secretion because of several S-gene mutations from a patient with fulminant hepatitis. J Pediatr Gastroenterol Nutr. 2002 Apr;34(4):426.

5396.      Dieterich DT. Treatment of hepatitis C and anemia in human immunodeficiency virus-infected patients. J Infect Dis. 2002 May 15;185 Suppl 2:S128-37. Review.

5397.      Dodi F, Alessandrini A, Camera M, Gaffuri L, Morandi N, Pagano G. Stevens-Johnson syndrome in HIV patients treated with nevirapine: two case reports. AIDS. 2002 May 24;16(8):1197-8.

5398.      Drago F, Rebora A. Cutaneous immunologic reactions to hepatitis B virus vaccine. Ann Intern Med. 2002 May 21;136(10):780; discussion 780-1.

5399.      El-Zayadi AR, Selim O, Hamdy H, El-Tawil A, Moustafa H. Heavy cigarette smoking induces hypoxic polycythemia (erythrocytosis) and hyperuricemia in chronic hepatitis C patients with reversal of clinical symptoms and laboratory parameters with therapeutic phlebotomy. Am J Gastroenterol. 2002 May;97(5):1264-5.

5400.      Griffiths A, Olynyk JK. Iron and the response to treatment of hepatitis C. Am J Gastroenterol. 2002 Apr;97(4):788-90.

5401.      Gupta R, Singh S, Tang R, Blackwell TA, Schiffman JS. Anterior ischemic optic neuropathy caused by interferon alpha therapy. Am J Med. 2002 Jun 1;112(8):683-4.

5402.      Hill JB, Sheffield JS, Kim MJ, Alexander JM, Sercely B, Wendel GD. Risk of hepatitis B transmission in breast-fed infants of chronic hepatitis B carriers. Obstet Gynecol. 2002 Jun;99(6):1049-52.

5403.      Holtzman JL. The effect of alcohol on acetaminophen hepatotoxicity. Arch Intern Med. 2002 May 27;162(10):1193.

5404.      Jeantet D, Chemin I, Mandrand B, Zoulim F, Trepo C, Kay A. Characterization of two hepatitis B virus populations isolated from a hepatitis B surface antigen-negative patient. Hepatology. 2002 May;35(5):1215-24.

5405.      Kawa S, Ota M, Yoshizawa K, Horiuchi A, Hamano H, Ochi Y, Nakayama K, Tokutake Y, Katsuyama Y, Saito S, Hasebe O, Kiyosawa K. HLA DRB10405-DQB10401 haplotype is associated with autoimmune pancreatitis in the Japanese population. Gastroenterology. 2002 May;122(5):1264-9.

5406.      Kazim SN, Wakil SM, Khan LA, Hasnain SE, Sarin SK. Vertical transmission of hepatitis B virus despite maternal lamivudine therapy. Lancet. 2002 Apr 27;359(9316):1488-9.

5407.      Kladney RD, Cui X, Bulla GA, Brunt EM, Fimmel CJ. Expression of GP73, a resident Golgi membrane protein, in viral and nonviral liver disease. Hepatology. 2002 Jun;35(6):1431-40.

5408.      Kondili LA, Chionne P, Costantino A, Villano U, Lo Noce C, Pannozzo F, Mele A, Giampaoli S, Rapicetta M.  Infection rate and spontaneous seroreversion of anti-hepatitis C virus during the natural course of hepatitis C virus infection in the general population. Gut. 2002 May;50(5):693-6.

5409.      Lauret E, Rodriguez M, Gonzalez S, Linares A, Lopez-Vazquez A, Martinez-Borra J, Rodrigo L, Lopez-Larrea C. HFE gene mutations in alcoholic and virus-related cirrhotic patients with hepatocellular carcinoma. Am J Gastroenterol. 2002 Apr;97(4):1016-21.

5410.      Manesis EK, Papatheodoridis GV, Hadziyannis SJ. Serum HBV-DNA levels in inactive hepatitis B virus carriers. Gastroenterology. 2002 Jun;122(7):2092-3; discussion 2093.

5411.      Mazoff CD. Re: J. Gross editorial--"Hepatitis C: a sexually transmitted disease?". Am J Gastroenterol. 2002 May;97(5):1256; discussion 1256-7.

5412.      Naoumov NV. SEN viruses and treatment response in chronic hepatitis C virus. Lancet. 2002 May 18;359(9319):1779-80; discussion 1780.

5413.      Okan V, Araz M, Aktaran S, Karsligil T, Meram I, Bayraktaroglu Z, Demirci F.  Increased frequency of HCV but not HBV infection in type 2 diabetic patients in Turkey. Int J Clin Pract. 2002 Apr;56(3):175-7.

5414.      Okita M, Sasagawa T, Tomioka K, Hasuda K, Ota Y, Suzuki K, Watanabe A.  Habitual food intake and polyunsaturated fatty acid deficiency in liver cirrhosis. Nutrition. 2002 Apr;18(4):304-8.

5415.      Oviedo J, Wolfe MM. Alcohol, acetaminophen, and toxic effects on the liver. Arch Intern Med. 2002 May 27;162(10):1194-5.

5416.      Patel PA, Voigt MD. Prevalence and interaction of hepatitis B and latent tuberculosis in Vietnamese immigrants to the United States. Am J Gastroenterol. 2002 May;97(5):1198-203.

5417.      Radaeva S, Jaruga B, Hong F, Kim WH, Fan S, Cai H, Strom S, Liu Y, El-Assal O, Gao B. Interferon-alpha activates multiple STAT signals and down-regulates c-Met in primary human hepatocytes. Gastroenterology. 2002 Apr;122(4):1020-34.

5418.      Redondo-Cerezo E, Nogueras-Lopez F, Martin-Vivaldi R, Simon EE. Fulminant hepatic failure as the presenting form of type 1 autoimmune hepatitis in the elderly. Am J Gastroenterol. 2002 May;97(5):1265-6.

5419.      Ross RS, Viazov S, Roggendorf M. Phylogenetic analysis indicates transmission of hepatitis C virus from an infected orthopedic surgeon to a patient. J Med Virol. 2002 Apr;66(4):461-7.

5420.      Ross RS, Viazov S, Thormahlen M, Bartz L, Tamm J, Rautenberg P, Roggendorf M, Deister A. Risk of hepatitis C virus transmission from an infected gynecologist to patients: results of a 7-year retrospective investigation. Arch Intern Med. 2002 Apr 8;162(7):805-10.

5421.      Singh N, Husain S, Carrigan DR, Knox KK, Weck KE, Wagener MM, Gayowski T.  Impact of human herpesvirus-6 on the frequency and severity of recurrent hepatitis C virus hepatitis in liver transplant recipients. Clin Transplant. 2002 Apr;16(2):92-6.

5422.      Soll AH, Sees KL.  Is acetaminophen really safe in alcoholic patients? Arch Intern Med. 2002 May 27;162(10):1194.

5423.      Takahashi K, Kang JH, Ohnishi S, Hino K, Mishiro S. Genetic heterogeneity of hepatitis E virus recovered from Japanese patients with acute sporadic hepatitis. J Infect Dis. 2002 May 1;185(9):1342-5.

5424.      Tazawa J, Maeda M, Nakagawa M, Ohbayashi H, Kusano F, Yamane M, Sakai Y, Suzuki K. Diabetes mellitus may be associated with hepatocarcinogenesis in patients with chronic hepatitis C. Dig Dis Sci. 2002 Apr;47(4):710-5.

5425.      Thies N. Universal neonatal immunization for Hepatitis B. J Paediatr Child Health. 2002 Apr;38(2):211; discussion 211-2.

5426.      Thorpe LE, Ouellet LJ, Hershow R, Bailey SL, Williams IT, Williamson J, Monterroso ER, Garfein RS.  Risk of hepatitis C virus infection among young adult injection drug users who share injection equipment. Am J Epidemiol. 2002 Apr 1;155(7):645-53.

5427.      Tsutsumi T, Suzuki T, Shimoike T, Suzuki R, Moriya K, Shintani Y, Fujie H, Matsuura Y, Koike K, Miyamura T.  Interaction of hepatitis C virus core protein with retinoid X receptor alpha modulates its transcriptional activity. Hepatology. 2002 Apr;35(4):937-46.

5428.      Volberding P, Sullivan P. Introduction: the importance of identifying and treating complications of human immunodeficiency virus disease. J Infect Dis. 2002 May 15;185 Suppl 2:S103-4.

5429.      Woitas RP, Ahlenstiel G, Iwan A, Rockstroh JK, Brackmann HH, Kupfer B, Matz B, Offergeld R, Sauerbruch T, Spengler U. Frequency of the HIV-protective CC chemokine receptor 5-Delta32/Delta32 genotype is increased in hepatitis C. Gastroenterology. 2002 Jun;122(7):1721-8.

5430.      Wong WH, Braunfeld M, Levin P. Recurrent pulmonary embolism during liver transplantation: possible role of hepatitis B immune globulin as a causative agent. Anesthesiology. 2002 May;96(5):1261-3.

5431.      Zepp F, Schuind A, Meyer C, Sanger R, Kaufhold A, Willems P. Safety and reactogenicity of a novel DTPa-HBV-IPV combined vaccine given along with commercial Hib vaccines in comparison with separate concomitant administration of DTPa, Hib, and OPV vaccines in infants. Pediatrics. 2002 Apr;109(4):e58.



5432.      Barnes-Nelson N. Doctors say all newborns need Hepatitis B shot. J Natl Med Assoc. 2002 Apr;94(4):A12.

5433.      Paul Y.  Hepatitis B immunization schedule recommended by IAP. Indian Pediatr. 2002 May;39(5):503-4; discussion 504-5.

5434.      Ray S, Samuel T, Hawker J, Smith S. Hepatitis B immunisation in renal units in the United Kingdom: questionnaire study. BMJ. 2002 Apr 13;324(7342):877-8.

5435.      Shiao JS, Mclaws ML, Huang KY, Guo YL. Student nurses in Taiwan at high risk for needlestick injuries. Ann Epidemiol. 2002 Apr;12(3):197-201.

Drugs :

5436.      Fuller CM, Vlahov D, Ompad DC, Shah N, Arria A, Strathdee SA. High-risk behaviors associated with transition from illicit non-injection to injection drug use among adolescent and young adult drug users: a case-control study. Drug Alcohol Depend. 2002 Apr 1;66(2):189-98.


Click Here for Abstract

Back To Content Page